Plasma levels and hepatic mRNA expression of transforming growth factor- β1 in patients with fulminant hepatic failure

Journal of Hepatology

Volumn 27, Issue 5, 1997, Pages 780-788

  Miwa, Yoshiyuki ^a   Harrison, Phillip M ^a   Farzaneh, Farzin ^a   Langley, Peter G ^a   Williams, Roger ^a   Hughes, Robin D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Fulminant hepatic failure; Hepatocyte growth factor; Transforming growth factor

Indexed keywords

PARACETAMOL; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEPATITIS NON A NON B; HUMAN; LIVER FAILURE; LIVER REGENERATION; MAJOR CLINICAL STUDY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; TISSUE REPAIR;

EID: 0030693864     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80313-3     Document Type: Article

References (43)

1. 1). Growth Factors. 8:1993;1-9.
2. Border W, Noble N. Transforming growth factor β in tissue fibrosis. N Engl J Med. 10:1994;1286-1292.
3. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N. Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci. 85:1988;1539-1543.
4. 1 and procollagen types I, III and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest. 85:1990;1833-1843.
5. Gentry LE, Webb NR, Lim G, Brunner AM, Ranchalis JE, Twardzik DR, et al. Type 1 transforming growth factor β: amplified expression and secretion of mature and precursor polypeptides in Chinese hamster ovary cells. Mol Cel Biol. 7:1987;3418-3427.
6. Nakamura T, Tomita Y, Hirai R, Yamaoka K, Kaji K, Ichihara A. Inhibitory effect of transforming growth factor β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun. 133:1985;1042-1050.
7. Carr BI, Hayashi I, Branum EL, Moses HL. Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type β transforming growth factor. Cancer Res. 46:1986;2330-2334.
8. Strain A, Frazer A, Hill D, Milner R. Transforming growth factor β inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver. Biochem Biophys Res Commun. 145:1987;436-442.
9. Russell W. Transforming growth factor beta (TGF-beta) inhibits hepatocyte DNA synthesis independently of EGF binding and EGF receptor autophosphorylation. J Cell Physiol. 135:1988;253-261.
10. Russell WE, Coffey RJ, Ouellette AJ, Moses HL. Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci. 85:1988;5126-5130.
11. Francavilla A, Starzl TE, Porter K, Foglieni CS, Michalopoulos GK. Screening for candidate hepatic growth factors by selective portal infusion after canine Eck fistula. Hepatology. 14:1991;665-670.
12. Czaja MJ, Weiner FR, Flanders KC, Giambrone MA, Wind R, Biempica L, et al. In vitro and in vivo association of transforming growth factor-β with hepatic fibrosis. J Cell Biol. 108:1989;2477-2482.
13. 1 gene expression in human liver disease. J Hepatol. 14:1992;259-264.
14. 1 and α in chronic liver disease. N Engl J Med. 324:1991;933-940.
15. Fang J, Bird G, Nakamura T, Davis G, Lau J. Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis. Lancet. 343:1994;820-823.
16. Rakela J, Lange S, Ludwig J, Baldus W. Fulminant hepatitis: Mayo Clinic experience with 34 cases. Mayo Clin Proc. 60:1985;289-292.
17. Schumperli D. Cell cycle regulation of histone gene expression. Cell. 45:1986;471-472.
18. Rickles R, Marashi F, Sierra F, Clark S, Wells J, Stein J, et al. Analysis of histone gene expression during the cell cycle in HeLa cells using cloned human histone genes. Proc Natl Acad Sci USA. 79:1982;749-753.
19. Trey C, Davidson C. The management of fulminant hepatic failure. Popper H, Schaffner F. Progress in Liver Disease. 3:1970;282-298 Grune & Stratton, New York.
20. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, et al. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology. 15:1991;1-5.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
22. 1 complementary DNA sequence and expression in normal and transformed cells. Nature (Lond.). 316:1985;701-705.
23. Tokunaga K, Nakamura Y, Sakata K, Fujimori K, Ohkubo M, Sawada K, et al. Enhanced expression of a glyceraldehdye-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res. 47:1987;5616-5619.
24. Feinberg A, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 132:1983;6-13.
25. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J Cell Biol. 106:1988;1059-1065.
26. Pernambuco JRB, Langley PG, Hughes RD, Izumi S, Williams R. Activation of the fibrinolytic system in patients with fulminant hepatic failure. Hepatology. 18:1993;1350-1356.
27. Assoian R, Komoriya A, Meyers C, Miller D, Sporn M. Transforming growth factor-β in human platelets: identification of a major storage site, purification and characterization. J Biol Chem. 258:1983;7155-7160.
28. Langley P, Forbes A, Hughes R, Williams R. Thrombin antithrombin III complex in fuminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcome. Eur J Clin Invest. 20:1990;627-631.
29. 1 isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF β Cell Regul. 2:1991;535-548.
30. Armendariz-Borunda J, Seyer J, Kang A, Raghow R. Regulation of TGF-β gene expression in rat liver intoxicated with carbon tetrachloride. FASEB. 4:1990;215-221.
31. Wolf HK, Michalopoulos GK. Hepatocyte regeneration in acute fulminant and nonfulminant hepatitis: a study of proliferating cell nuclear antigen expression. Hepatology. 15:1992;707-713.
32. Koukoulis G, Rayner A, Tan K-C, Williams R, Portmann B. Immunolocalization of regenerating cells after submassive liver necrosis using PCNA staining. J Pathol. 166:1992;359-368.
33. Hughes RD, Zhang L, Tsubouchi H, Daikuhara Y, Williams R. Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure. J Hepatol. 20:1994;106-111.
34. Muto Y, Nouri A, Meager A, Alexander G, Eddleston A, Williams R. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet. ii:1988;72-74.
35. Phan SH, Gharaee-Kermani M, McGarry B, Kunkel SL, Wolber FW. Regulation of rat pulmonary artery endothelial cell transforming growth factor-β production by IL-1 and tumor necrosis factor-α J Immunol. 149:1992;103-106.
36. 1 in mice. J Clin Invest. 87:1991;39-44.
37. 2-microglobulin plasma levels. Kidney Int. 40:1991;1110-1117.
38. 2-macroglobulins. Lab Invest. 65:1991;3-14.
39. Izumi S, Hughes RD, Langley PG, Pernambuco JRB, Williams R. Extent of the acute phase response in fulminant hepatic failure. Gut. 35:1994;982-986.
40. Pernambuco J, Hughes R, Langley P, Izumi S, Williams R. Hepatocyte growth factor and plasminogen activation in fulminant hepatic failure. Blood Coag Fibrinol. 5:1994;511-515.
41. Hrusovsky S, Tsubouchi H, Remy-Martin A, Jouvenot M, Adessi GL, Rouget C, et al. Human hepatocyte growth factor serum levels in early stages after orthotopic liver transplantation. Transplant Proc. 26:1994;3618-3619.
42. Liu K-X, Kato Y, Narukawa M, Kim DC, Hanano M, Higuchi O, et al. Importance of the liver in plasma clearance of hepatocyte growth factor in rats. Am J Physiol. 263:1992;G642-G649.
43. Waltenberger J, Wanders A, Fellström B, Miyazono K, Helden C-H, Funa K. Induction of transforming growth factor-β during cardiac allograft rejection. J Immunol. 151:1993;1147-1157.